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Abstract
Background: Homeless persons with HIV/AIDS have greater morbidity and mortality, more
hospitalizations, less use of antiretroviral therapy, and worse medication adherence than HIV-
infected persons who are stably housed. We examined the effect of homelessness on the mortality
of persons with AIDS and measured the effect of supportive housing on AIDS survival.
Methods: The San Francisco AIDS registry was used to identify homeless and housed persons who
were diagnosed with AIDS between 1996 and 2006. The registry was computer-matched with a
housing database of homeless persons who received housing after their AIDS diagnosis. The
Kaplan-Meier product limit method was used to compare survival between persons who were
homeless at AIDS diagnosis and those who were housed. Proportional hazards models were used
to estimate the independent effects of homelessness and supportive housing on survival after AIDS
diagnosis.
Results: Of the 6,558 AIDS cases, 9.8% were homeless at diagnosis. Sixty-seven percent of the
persons who were homeless survived five years compared with 81% of those who were housed (p
< 0.0001). Homelessness increased the risk of death (adjusted relative hazard [RH] 1.20; 95%
confidence limits [CL] 1.03, 1.41). Homeless persons with AIDS who obtained supportive housing
had a lower risk of death than those who did not (adjusted RH 0.20; 95% CL 0.05, 0.81).
Conclusion: Supportive housing ameliorates the negative effect of homelessness on survival with
AIDS.
Background
Homelessness is associated with excess morbidity and
mortality [1-4]. Homeless persons suffer from high rates
of substance abuse [5-7], mental illness [5,7-9], tubercu-
losis [10,11], infectious hepatitis [6,12-15], and insuffi-
cient health care [14,15].
Among HIV-infected persons, unstable housing has been
associated with fewer ambulatory care visits [16], greater
reliance on emergency departments [16-19], frequent or
longer hospitalizations [16,17,19,20], and decreased use
of antiretroviral therapy and prophylaxis against oppor-
tunistic illnesses [17,18,20,21]. Among homeless persons
who have been prescribed antiretroviral therapy, adher-
ence is suboptimal [17,22].
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Mortality among HIV-infected persons with unstable
housing has not been well-studied. Two studies found no
effect of homelessness on AIDS survival; however, one of
the studies was conducted before the availability of effec-
tive antiretroviral therapy [23] and the other did not
include HIV-infected persons with stable housing as a
comparison group [6]. More recently, a clinic-based, case-
control study of HIV patients [24] and an analysis of data
from two cohort studies of HIV infection and alcohol use
found that homelessness independently predicted mortal-
ity [25]. To date, however, no studies have examined the
effect of homelessness on AIDS survival in a population-
based sample or the effect of providing supportive hous-
ing on survival in the era of effective antiretroviral
therapy.
Methods
Study population
All adult and adolescent (aged 13 years) San Francisco
residents who were diagnosed with AIDS from January 1,
1996 through December 31, 2006 and reported to the San
Francisco Department of Public Health (SFDPH) by
November 30, 2007 were included in the study. The AIDS
surveillance system is evaluated annually and consistently
found to be over 95% complete [26].
More than 90% of AIDS cases undergo a complete medi-
cal chart review at the time of report with records re-
reviewed and updated every 18–24 months. Data col-
lected include demographic and risk information, insur-
ance status, AIDS-defining illnesses, results of HIV, CD4,
and viral load tests, date of initiation and type of antiret-
roviral therapies, and of prophylaxis against Pneumocystis
jirovecii pneumonia (PCP) and Mycobacterium avium com-
plex (MAC).
Housing status is collected at diagnosis. Cases were con-
sidered to be homeless if the medical record noted that
the patient was homeless or if the address recorded was a
known homeless shelter, a health care clinic, or a free
postal address not connected to a residence (e.g., general
delivery). Persons with missing addresses in the medical
record were considered to be housed.
Documentation of deaths was obtained through weekly
review of local death certificates, reports from other health
departments, and annual matches with the National
Death Index, which includes deaths through 2005.
Underlying and contributory causes of death were coded
according to the International Classification of Diseases –
9th and 10th revisions.
Comparison of survival among homeless and housed 
persons
Differences in the characteristics of homeless and housed
persons were assessed using the chi square test for differ-
ences in proportions and the t  test for differences in
means. The Kaplan-Meier method was used to estimate
the distribution of the time from AIDS diagnosis to death
among homeless and housed persons; cases not known to
have died were censored at the more recent of either the
date of their last follow-up or December 31, 2005. The
log-rank test was used to assess differences in survival. As
with previous studies of AIDS survival, we used all-cause
mortality [27-29].
A Cox proportional hazards model was used to estimate
the independent associations of housing status with mor-
tality. For the multivariable analysis, we included demo-
graphic and risk characteristics, insurance status at
diagnosis, the AIDS-defining condition (low CD4 count
versus an opportunistic illness), the CD4 count at diagno-
sis, use of antiretroviral therapy (as a time-dependent var-
iable), and prophylaxis against PCP and MAC.
To assess the proportionality assumption, we checked for
interaction between each risk factor and time since AIDS
diagnosis; for highly active antiretroviral therapy, a time-
dependent covariate, we assessed interaction with time
since start of treatment. Because the risk associated with
homelessness increased during the study period (p <
0.05), we calculated the estimated relative hazard (RH) at
one, three, and five years after diagnosis. Results did not
suggest qualitative changes from harm to protection or
from protection to harm; therefore, we also calculated a
summary RH for this predictor, averaged over the entire
follow-up period.
To examine in more detail the factors related to high mor-
tality in homeless people, we compared the five most fre-
quent contributory causes of deaths among homeless and
housed AIDS cases, as obtained from the National Death
Index.
Effect of obtaining housing on AIDS survival
The SFDPH provides supportive housing services to
homeless persons who have the most severe or greatest
number of chronic medical or psychiatric needs, or both,
through the Direct Access to Housing (DAH) program.
The program houses people directly from shelters, street
living situations, or institutions. Residents must pay rent
on a sliding scale of 30% to 50% of their income; those
who are ineligible for public entitlements are housed for
free. All DAH sites have dedicated case managers and pro-
vide medical services that range from an on-site, full-time
nurse and part-time, mid-level clinician (e.g. nurse practi-
tioner) to obtaining care at designated health careBMC Public Health 2009, 9:220 http://www.biomedcentral.com/1471-2458/9/220
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facilities located near the DAH residences. Supportive
housing services were initiated in 1999, although the
DAH program database includes move-in dates as early as
1992. The database contains the names, dates of birth,
and move-in dates of persons who are housed by the
program.
To identify homeless AIDS cases who obtained DAH
housing, we computer matched the AIDS case registry to
the DAH database using the patient name and date of
birth as the matching variables. Cases who did not match
using these criteria were matched using the soundex code
(an alpha numeric code that allows for minor differences
in the spelling of names) of the last name, first initial of
the first name, and date of birth. All matches were manu-
ally reviewed. When available, matched cases were further
compared using sex and race. To be classified as a home-
less AIDS patient who obtained DAH housing, the move-
in date must have been after diagnosis. By matching all
AIDS cases to the DAH database, we identified persons
who were not originally reported as homeless but received
supportive housing. Because the DAH program offers
housing only to persons who have been identified by their
case manager as homeless, AIDS cases who were housed
through DAH were included in the analysis of the impact
of housing on survival and considered to have been
homeless at the time of diagnosis as long as housing was
obtained after the AIDS diagnosis. Such individuals were
likely misclassified as housed at AIDS diagnosis or they
may have become homeless sometime later.
Differences in the characteristics of homeless persons who
received housing and those who did not were assessed
using the chi square test for categorical variables and the t
test for continuous variables. A multivariable propor-
tional hazards model was performed to estimate the inde-
pendent association of supportive housing with mortality.
Obtaining public housing was included as a time-depend-
ent variable to avoid creating a survival bias among those
surviving long enough to obtain housing. Included in the
multivariable model were demographic and risk charac-
teristics, the AIDS-defining diagnosis (low CD4 count or
opportunistic illness), the CD4 count at diagnosis, use of
antiretroviral therapy (as a time-dependent variable), and
prophylaxis against PCP and MAC. Because there were so
few cases with private insurance, this variable was
excluded from the model. The proportionality assump-
tion was assessed using the methods previously described.
No statistically significant violations were found.
Estimating the cost per year of life saved of providing 
housing
To estimate the increase in average survival time over the
first five years in supportive housing, we matched each
homeless AIDS case who obtained housing to one control
who did not. The cases and controls were matched by date
of AIDS diagnosis (plus or minus six months), CD4 count
at diagnosis (100, 101–200, >200), age at diagnosis (<40
years to 40 years), and whether they had injected drugs.
Some cases matched with more than one control; in this
situation, we selected the control whose date of diagnosis
and CD4 cell count most closely matched. To avoid both
a survival bias and a potential bias from controls being
denied housing because of imminent death, controls were
required to survive at least the same number of months
from date of diagnosis as the case at the time that the case
obtained housing and at least three months beyond the
date that the case obtained housing. Follow-up time for
cases and controls began the date the case obtained
housing.
Using the matched sample, we estimated the increase in
mean survival time over the first five years after receipt of
housing for cases and their matched controls by calculat-
ing the difference in areas under the Kaplan-Meier survival
curves [30]. The survival time for cases and controls still
alive and in follow-up five years or more after receiving
supportive housing was considered to be five years. Hous-
ing costs were limited to those incurred by the health
department: the lease, property management, and sup-
port services. We estimated the cost of housing as the
restricted mean survival time in the housed group multi-
plied by the average monthly cost of housing. The cost per
year of life saved then was estimated as the annualized
average cost of housing divided by the increase in the
restricted mean survival gain associated with housing. We
used bootstrap methods to compute 95% bias-corrected
percentile confidence limits (CL) for restricted mean sur-
vival, survival gain from housing, and the cost per year of
life saved [31].
Figure 1 displays the derivation and composition of the
samples used in each of the analyses. In the proportional
hazards models, records with missing values were
excluded. Analyses were done using SAS (SAS Institute,
Cary, North Carolina) and Stata software (StataCorp, Col-
lege Station, Texas). The study protocol was approved by
the Institutional Review Board of the University of Cali-
fornia, San Francisco.
Results
Comparison of persons by housing status at the time of 
AIDS diagnosis
Of the 6,558 AIDS cases included in this analysis, 641
(9.8%) were homeless at diagnosis. Homeless cases were
more likely to be women or transgender, less than 30
years old, African American, and injection drug users, to
have public health insurance or to be uninsured, and to be
less likely to be aged 50 years or older, or to be receivingBMC Public Health 2009, 9:220 http://www.biomedcentral.com/1471-2458/9/220
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antiretroviral therapy than were the housed cases (Table
1).
Survival was significantly worse for homeless persons.
Sixty-seven percent of persons who were homeless at the
time of AIDS diagnosis survived five years compared with
81% of housed persons (p < 0.0001, Figure 2).
After adjustment for potential confounders, homelessness
was significantly associated with increased mortality (RH
1.20; 95% CL 1.03, 1.41; Table 2). The analysis of the
changes in the RH over time showed that the adjusted
increase in the risk of mortality associated with homeless-
ness increased from 1.00 (95% CL 0.82, 1.22) at one year,
to 1.22 (95% CL 1.04, 1.42) at three years, and to 1.48
(95% CL 1.22, 1.79) at five years.
Other significant predictors of mortality were older age at
diagnosis (RH 1.67; 95% CL 1.50, 1.86), injection drug
use among persons other than men who have sex with
men (MSM) (RH 1.88; 95% CL 1.59, 2.23), injection drug
use among MSM (RH 1.52; 95% CL 1.32, 1.76), hetero-
sexual contact (RH 1.48; 95% CL 1.14, 1.93), having pub-
lic or no health insurance at diagnosis (RH 2.12; 95% CL
1.82, 2.48 and RH 1.60; 95% CL 1.39, 1.84, respectively),
and having an opportunistic illness as the AIDS defining
diagnosis (RH 1.41; 95% CL 1.24, 1.60). Use of antiretro-
viral therapy, prophylaxis against PCP, and higher CD4
counts at diagnosis were all associated with decreased risk
of death (Table 2).
Although HIV/AIDS was the most frequent cause of death
for all homeless persons with AIDS, the proportion of
homeless persons who died from HIV/AIDS was signifi-
cantly lower than for housed cases (Table 3). Causes of
This figure displays the samples used to construct each table Figure 1
This figure displays the samples used to construct each table. This figure shows where each of the samples used in the 
analyses that produced the results displayed in each of the tables as well as the reason that data were added or deleted.
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Table 1: Characteristics of persons diagnosed with AIDS in San Francisco, 1996–2006, by housing status at diagnosis (N = 6558)
Characteristics Homeless Non-Homeless
(N = 641) (N = 5917)
N% N % P  v a l u e *
Gender <0.0001
Male 497 77.54 5363 90.64
Female 94 14.66 399 6.74
Transgender 50 7.80 155 2.62
Age at diagnosis (years) 0.0003
13–29 83 12.95 539 9.11
30–39 255 39.78 2361 39.90
40–49 229 35.73 2032 34.34
50+ 74 11.54 985 16.65
Race/ethnicity <0.0001
White 260 40.56 3646 61.62
African American 252 39.31 963 16.28
Latino 106 16.54 944 15.95
Asian/Pacific Islander/Native American/Other 23 3.59 364 6.15
Risk group <0.0001
Men who have sex with men 135 21.06 4098 69.26
Injection drug user 257 40.09 634 10.71BMC Public Health 2009, 9:220 http://www.biomedcentral.com/1471-2458/9/220
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Men who have sex with men and inject drugs 213 33.23 881 14.89
Heterosexual/Other 36 5.62 304 5.14
Insurance status <0.0001
Public 212 33.07 1205 20.37
Private 7 1.09 2628 44.41
None 408 63.65 1906 32.21
Unknown 14 2.18 178 3.01
Initial AIDS diagnosis 0.3518
CD4 count <200 cells/mm3 503 78.47 4735 80.02
Opportunistic illness 138 21.53 1182 19.98
CD4 count at diagnosis (mean cells/mm3)† 172 184 0.0346
Ever received highly active antiretroviral therapy <0.0001
Yes 454 70.83 4870 82.31
No 187 29.17 1047 17.69
Ever received prophylaxis against Pneumocystis jirovecii pneumonia
Yes 417 65.05 3384 57.19 0.0001
No 224 34.95 2533 42.81
Table 1: Characteristics of persons diagnosed with AIDS in San Francisco, 1996–2006, by housing status at diagnosis (N = 6558) BMC Public Health 2009, 9:220 http://www.biomedcentral.com/1471-2458/9/220
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death that are associated with substance use (e.g., hepati-
tis, other causes of liver disease, septicemia) and mental
illness occurred more frequently among the homeless. In
contrast, chronic diseases were the most frequent non-
HIV/AIDS-related causes of death among the housed
cases.
Impact of obtaining housing on AIDS survival
Seventy AIDS cases matched with the DAH database and
had move-in dates that were later than the AIDS diagnosis
date, 35 of these cases were listed as homeless in the AIDS
registry at the time of diagnosis and the other 35 were
added after database matching. The result was a total of
676 homeless persons for this analysis (70 housed and
606 non-housed). The characteristics of persons who
received housing and those who did not were similar
except those who received housing were older (Table 4).
Of the 676 persons characterized in Table 4, 652 had com-
plete data and were included in the proportional hazards
model. Of these, there were two deaths among persons
who received supportive housing, 219 deaths among
those who were not housed, and 431 censored cases. After
Ever received prophylaxis against Mycobacterium avium complex
Yes 173 26.99 1099 18.57 <0.0001
No 468 73.01 4818 81.43
* Chi square test for differences in proportions and t test for differences in means.
† Excludes 205 cases that were missing CD4 results.
Table 1: Characteristics of persons diagnosed with AIDS in San Francisco, 1996–2006, by housing status at diagnosis (N = 6558) 
Kaplan-Meier survival curves for San Francisco AIDS cases diagnosed between 1996–2006, by housing status at diagnosis Figure 2
Kaplan-Meier survival curves for San Francisco AIDS cases diagnosed between 1996–2006, by housing status at 
diagnosis. The data displayed represent the proportion of persons living (in months) following the date of their AIDS diagno-
sis, stratified by housing status at the time of AIDS diagnosis (housed, or homeless). x axis: time (months)y axis: proportion 
(percent) surviving
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Table 2: Multivariable predictors of mortality among persons diagnosed with AIDS in San Francisco, 1996–2006 (N = 6163)*
Characteristics Adjusted Relative Hazard 95% Confidence Limits
Homeless at AIDS diagnosis
No Referent
Yes 1.20 1.03, 1.41
Gender
Male Referent
Female 0.80 0.65, 0.98
Transgender 1.14 0.87, 1.51
Age at diagnosis (years)
<40 Referent
 40 1.67 1.50, 1.86
Race/ethnicity
White Referent
African American 0.96 0.83, 1.10
Latino 0.83 0.70, 0.98
Asian/Pacific Islander/Native American/Other 0.77 0.59, 0.99
Risk group
Men who have sex with men ReferentBMC Public Health 2009, 9:220 http://www.biomedcentral.com/1471-2458/9/220
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Injection drug user 1.88 1.59, 2.23
Men who have sex with men and inject drugs 1.52 1.32, 1.76
Heterosexual/Other 1.48 1.14, 1.93
Insurance status
Private Referent
Public 2.12 1.82, 2.48
None 1.60 1.39, 1.84
Initial AIDS diagnosis
CD4 count < 200 cells/mm3 Referent
Opportunistic illness 1.41 1.24, 1.60
CD4 count at diagnosis† 0.90 0.88, 0.92
Ever received highly active antiretroviral therapy
No Referent
Yes 0.82 0.72, 0.93
Ever received prophylaxis against Pneumocystis jirovecii pneumonia
No Referent
Yes 0.89 0.80, 1.00
Table 2: Multivariable predictors of mortality among persons diagnosed with AIDS in San Francisco, 1996–2006 (N = 6163)* (Continued)BMC Public Health 2009, 9:220 http://www.biomedcentral.com/1471-2458/9/220
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adjusting for potentially confounding variables, obtaining
supportive housing was independently associated with an
80% reduction in mortality (RH 0.20; 95% CL 0.05, 0.81;
Table 5). Mortality also was significantly lower for African
Americans and persons with higher CD4 counts at diag-
nosis and significantly higher for persons 40 years or older
at diagnosis and injection drug users.
To assess the possible effect of misclassification due to
some housed patients not being initially coded as home-
less in the AIDS registry, we repeated the multivariable
Cox proportional hazards regression excluding these 35
cases. The RH for receiving housing (0.29) was similar to
that found in our main analysis (0.20), although with this
smaller sample the 95% CL included one (0.07, 1.20).
It is possible that unmeasured characteristics could
explain the 80% reduction in mortality from supportive
housing, and we determined the conditions that would be
needed for this to occur (see Appendix). Specifically, we
considered binary confounders of prevalence from 10%
to 90% and correlations with not receiving housing that
ranged from 0.1 to 0.5. For each combination, we calcu-
lated the strength of the association between the omitted
confounder and mortality that would completely explain
the reduction. In one scenario, we found that an unmeas-
ured confounder affecting 70% of the population and cor-
related at 0.5 with not receiving supportive housing
would be needed to cause a nine-fold increase in mortality
to explain the apparent protective effect of receiving
housing.
Estimating the cost per year of life saved of providing 
housing
We identified 49 case-control pairs. The restricted mean
survival time during the first five years of follow-up was
57.2 months (95% bootstrap CL, 51.7, 60.0) for the
housed cases and 42.5 months (95% bootstrap CL, 33.4,
51.2) for the matched controls, resulting in an average
gain of 14.7 months. At an approximate cost of $1,000 per
month, the average cost of housing per year of life saved
was $ 46,800 (95% bootstrap CL, $28,946, $171,746).
Discussion
Homeless persons with AIDS had significantly worse sur-
vival than housed persons, and the provision of housing
after AIDS improved survival. These findings have impor-
tant policy implications given that supportive housing is
a feasible and affordable intervention.
Several factors associated with homelessness are likely to
have contributed to the poorer survival in this group,
including drug use, serious mental illness, inadequate use
of health care, and poor adherence to medications. Con-
sistent with prior studies, antiretroviral use was lower
among homeless compared to housed AIDS cases
[17,18,21]. Although we adjusted our model for initiation
of antiretroviral use, we did not have data on compliance
Ever received prophylaxis against Mycobacterium avium complex
No Referent
Yes 0.94 0.83, 1.07
* Excludes cases without follow-up or with missing values.
† Included as a continuous variable using incremental categories of 50 cells.
Table 2: Multivariable predictors of mortality among persons diagnosed with AIDS in San Francisco, 1996–2006 (N = 6163)* (Continued)
Table 3: Multiple causes of death among persons diagnosed with 
AIDS between 1996 and 2005, by homeless status at diagnosis
Homeless Housed
Cause of death N (%) N (%)
HIV/AIDS 156 (78%) 905 (83%)
Hepatitis 41 (21%) 130 (12%)
Liver disease 39 (20%) 160 (15%)
Septicemia 35 (18%) 121 (11%)
Mental illness 33 (17%) 52 (5%)
Heart disease 29 (15%) 201 (18%)
Pneumonia (non-AIDS-related) 27 (14%) 172 (16%)
Non-AIDS cancer 12 (6%) 139 (13%)
P = 0.02 using the chi square test for differences between HIV/AIDS-
related deaths and non-HIV/AIDS-related deaths.BMC Public Health 2009, 9:220 http://www.biomedcentral.com/1471-2458/9/220
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Table 4: Characteristics of homeless persons with AIDS who did and did not receive health department supportive housing, in San 
Francisco, 1996–2006 (N = 676)*
Characteristics Received Supportive Housing
Yes No
(N = 70) (N = 606)
N % N % P value†
Gender 0.1448
Male 48 68.57 472 77.89
Female 16 22.86 86 14.19
Transgender 6 8.57 48 7.92
Age at diagnosis (years) 0.0637
13–29 8 11.43 82 13.53
30–39 22 31.43 244 40.26
40–49 25 35.71 214 35.31
50+ 15 21.43 66 10.89
Race/ethnicity 0.5319
White 27 38.57 248 40.92
African American 28 40.00 237 39.11
Latino 10 14.29 99 16.34
Asian/Pacific Islander/Native American/Other 5 7.14 22 3.63
Risk group 0.2825
Men who have sex with men 19 27.14 123 20.30BMC Public Health 2009, 9:220 http://www.biomedcentral.com/1471-2458/9/220
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Injection drug user 31 44.29 241 39.77
Men who have sex with men and inject drugs 17 24.29 207 34.16
Heterosexual/Other 3 4.29 35 5.78
Insurance status 0.0695
Public 26 37.14 205 33.83
Private 34 . 2 9 5 0 . 8 3
None 40 57.14 383 63.20
Unknown 1 1.43 13 2.15
Initial AIDS diagnosis 0.9964
CD4 count <200 cells/mm3 55 78.57 476 78.55
Opportunistic illness 15 21.43 130 21.45
CD4 count at diagnosis (mean cells/mm3)‡ 176 172 0.8368
Ever received highly active antiretroviral therapy 0.1052
Yes 56 80.00 429 70.79
No 14 20.00 177 29.21
Ever received prophylaxis against Pneumocystis jirovecii pneumonia 0.7236
Yes 47 67.14 394 65.02
No 23 32.86 212 34.98
Table 4: Characteristics of homeless persons with AIDS who did and did not receive health department supportive housing, in San 
Francisco, 1996–2006 (N = 676)* (Continued)BMC Public Health 2009, 9:220 http://www.biomedcentral.com/1471-2458/9/220
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with regimens, length of time patients were treated,
adverse reactions, or development of resistance. Several
studies among HIV-infected homeless persons have docu-
mented high rates discontinuation of antiretroviral medi-
cations and treatment interruption [17,22]. In addition,
HIV-infected homeless persons have fewer ambulatory
care visits than infected persons who are housed [20].
These unmeasured factors could bias away from the null
our estimate of the adverse effect of homelessness.
Injection drug use was more common among homeless
than housed persons and was an independent predictor of
mortality in our study as well as in others [32,33]. Injec-
tion drug use has been associated with premature mortal-
ity, [34,35] due in large part to overdose, suicide,
homicide, accidents, and liver disease [34,36,37]. A large
proportion of the non-HIV-related deaths among home-
less AIDS cases was due to these drug-related causes.
Persons with heterosexually acquired HIV were at
increased risk of death. This finding is consistent with
some [33,38] but not all [32,39] studies of AIDS survival.
Previous studies of persons with HIV/AIDS in San Fran-
cisco and nationally have documented that compared
with MSM, heterosexuals are more likely to be diagnosed
with HIV within 12 months of AIDS suggesting that they
are diagnosed with HIV later in the course of their disease,
a factor associated with worse survival [38,40].
Persons lacking private health insurance had an increased
risk of death. This finding is supported by other studies of
HIV-infected persons [24,41] and may reflect differential
access to care and/or treatment [42-45]. It is likely that
persons with private insurance received medical care by
private physicians who may be more available to manage
adverse reactions to medications and to facilitate uninter-
rupted use of antiretroviral therapy than providers in pub-
lic settings.
Prior studies have shown that housing the homeless,
including those with mental illness and substance abuse
problems, is feasible [46-48] and can be accomplished for
a modest cost [49]. Our study advances the field by dem-
onstrating that supportive housing can decrease mortality.
This finding may be due to housed persons being better
able to keep medical appointments, store their medica-
tions, and adhere to their regimen because housing pro-
vides a structure that contributes to a steady routine. The
medical and case management services that were provided
with the housing may have also contributed to the gains
in survival. Indeed, case management has been shown to
reduce unmet need and improve use of antiretroviral
medications among HIV-infected persons [50,51] and
reduce the number of hospital days and emergency
department visits among homeless persons with chronic
medical illness [48]. Housing may also result in decreased
substance use among HIV-infected persons [52].
This study has several limitations. We defined an individ-
ual as homeless at diagnosis based upon information in
the medical record. It is possible that persons with unsta-
ble housing gave an address at the time they were diag-
nosed that reflected a temporary housing situation, such
as staying with a friend or relative, and would have been
misclassified as housed. Also, an individual who was sta-
bly housed at diagnosis could have become homeless at a
later date. Similarly, someone who was homeless at diag-
nosis could have subsequently received housing. All of
these scenarios would have resulted in minimizing the
differences in survival between the housed and homeless
groups.
Although few AIDS cases are unreported, we investigated
the possibility that differences between reported and
unreported cases could have biased our results. The AIDS
surveillance system is evaluated annually for complete-
ness of reporting. This is done at selected sites where ICD-
10 codes that correspond to HIV, AIDS, and HIV-related
conditions are used to identify persons who may have
Ever received prophylaxis against Mycobacterium avium complex 0.9886
Yes 19 27.14 164 27.06
No 51 72.86 442 72.94
* Includes 35 additional cases not originally recorded as homeless at diagnosis but who matched with the housing database and had a move-in date 
that was later than the AIDS diagnosis date.
†Chi square test for differences in proportions and t test for differences in means.
‡Excludes 23 cases that were missing CD4 results.
Table 4: Characteristics of homeless persons with AIDS who did and did not receive health department supportive housing, in San 
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Table 5: Multivariable predictors of mortality among persons who were homeless at AIDS diagnosis in San Francisco, 1996–2006 (N = 
652)*
Characteristics Adjusted Relative Hazard 95% Confidence Limits
Received supportive housing
No Referent
Yes 0.20 0.05, 0.81
Gender
Male Referent
Female 0.78 0.51, 1.19
Transgender 0.77 0.43, 1.38
Age at diagnosis (years)
<40 Referent
 40 1.46 1.10, 1.94
Race/ethnicity
White Referent
African American 0.73 0.54, 1.00
Latino 0.97 0.64, 1.46
Asian/Pacific Islander/Native American/Other 0.55 0.22, 1.35
Risk group
Men who have sex with men ReferentBMC Public Health 2009, 9:220 http://www.biomedcentral.com/1471-2458/9/220
Page 15 of 18
(page number not for citation purposes)
Injection drug user 1.87 1.24, 2.82
Men who have sex with men and inject drugs 1.47 0.97, 2.22
Heterosexual/Other 1.45 0.67, 3.13
Initial AIDS diagnosis
CD4 count < 200 cells/mm3 Referent
Opportunistic illness 1.31 0.94, 1.82
CD4 count at diagnosis† 0.92 0.86, 0.97
Ever received highly active antiretroviral therapy
No Referent
Yes 1.08 0.79, 1.47
Ever received prophylaxis against Pneumocystis jirovecii pneumonia
No Referent
Yes 0.82 0.60, 1.11
Ever received prophylaxisagainst Mycobacterium avium complex
No Referent
Yes 1.01 0.75, 1.37
* Excludes cases without follow-up or with missing values.
† Included as a continuous variable using incremental categories of 50 cells.
Table 5: Multivariable predictors of mortality among persons who were homeless at AIDS diagnosis in San Francisco, 1996–2006 (N = 
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HIV. The list is matched against the HIV/AIDS registry to
identify persons who may have been missed. The medical
records of persons who did not match with the registry are
reviewed to identify persons with HIV/AIDS. Any missed
cases are reported and the reporting source is listed as
coming from the evaluation. We examined characteristics
of cases that were initially not reported but later found
during annual evaluations of the surveillance system for
the years 1996 through 2002. Missed cases were signifi-
cantly (p < 0.05) more likely to be housed, white, alive at
diagnosis, and to have private health insurance (data not
shown). Thus, in order for unreported cases to have
biased our results, these cases would have to have worse
survival than the reported housed cases, a scenario that we
believe is unlikely. Missed cases may impact the generaliz-
ability of our findings but because AIDS case reporting is
so complete, such an effect would be small.
In our analysis we used all cause mortality. We know that
homeless persons are more likely to die from non-AIDS-
related causes than are housed persons. To assess the
impact of using all cause mortality, we excluded persons
whose primary cause of death was not HIV/AIDS and con-
ducted another Cox proportional hazards model with this
restricted dataset. Our findings were essentially
unchanged (RH for homeless 1.19; 95% CL 1.00, 1.42).
As with any nonrandomized comparison of an interven-
tion, the most significant limitation to our analysis is the
possibility that persons who were housed were not equiv-
alent to those who remained homeless in unmeasured, or
measured but inadequately modeled, characteristics. In
particular, if those who received housing were more likely
than those who were not housed to survive even if they
did not receive housing, the validity of the comparison
would be undermined. Several factors argue against this
outcome applying to this study. First, the supportive hous-
ing program seeks to house people with the greatest med-
ical and/or psychosocial need. Second, the comparisons
between housed and not housed persons showed the
groups to be remarkably similar. The strongest difference
was that the housed group was more than twice as likely
to be aged 50 years or more, a strong predictor of worse
survival, and corroborating evidence that the program
houses persons in greatest need. Persons who were home-
less at diagnosis may have received housing subsequently
from sources other than the DAH program, which would
have caused underestimation of the effect providing sup-
portive housing has on mortality. The results of the sensi-
tivity analysis indicate that it is unlikely that unmeasured
confounding could account for our findings.
Although this study used a population-based sample of
persons with AIDS, the findings may not be representative
of persons with AIDS outside of this geographic region. In
San Francisco, HIV is overwhelmingly a disease of MSM.
Although this risk group still accounts for the majority of
cases nationwide, heterosexual injection drug users and
heterosexual partners of injection drug users account for a
larger proportion of AIDS cases elsewhere than occurs in
San Francisco.
The annual costs per person housed are comparable to
those reported from a multisite study of supportive hous-
ing for HIV-infected persons [53] and the cost of support-
ive housing per year of life saved ($46,800) was within the
range of approved medical interventions [54,55]. Because
of our small sample size, the upper 95% CL exceeded the
usual cut-off for cost-effective interventions. Our cost-
effectiveness analysis, however, was very conservative in
that we considered only the direct cost of the intervention
and did not include any of the expected medical care
reductions due to providing supportive housing [46]. A
large study of supportive housing for the mentally ill in
New York City found that 95% of the costs of supportive
housing are recouped through savings on hospitalizations
and shelter stays [56]. Assuming that only 70% of these
costs were recouped, the cost per year of life saved
becomes highly cost-effective in our population
($14,040). The cost-effectiveness of housing also would
be enhanced if it were quality adjusted, given the gain in
quality of life due to being housed versus living on the
street.
Conclusion
This study presents observational data showing a survival
benefit from supportive housing. Only a randomized con-
trolled trial could definitively demonstrate that support-
ive housing reduces AIDS mortality but the follow-up
time required for such a study would make it difficult to
complete. In the absence of such trial data, we believe that
the strengths and plausibility of our findings demonstrate
the need to make housing programs a priority for persons
with AIDS. Unfortunately, the major federal program for
the care of HIV-infected persons, the Ryan White CARE
Act, explicitly restricts localities from using funds for long-
term housing. Policy makers should recognize that sup-
portive housing can be a cost-effective intervention for
reducing mortality in persons with AIDS and provide the
mechanisms necessary to ensure that persons in need may
receive its benefits.
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Appendix: Assumptions and formula used in the 
sensitivity analysis
Suppose that the true RH for the factor of interest, after
adjustment for the unmeasured confounder, is actually
1.0, or equivalently the true regression coefficient 1 is
zero. Then 2, the coefficient or log-RH for the unmeas-
ured confounder, has to be approximately
where b1 is the confounded estimate of 1, f1 and f2 are the
prevalence of the primary predictor and unmeasured con-
founder respectively, and r  is the correlation between
them.
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